Valued at $75.0M at its later-stage round, Oct 2025. Nothing has traded since.
- ·Watch Vergent Bioscience: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Vergent Bioscience funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC | $18.7M | ▮ | ▮ |
| Feb 2025 | Seed Round | $3.8M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $21.5M | ▮ | ▮ |
| Nov 2021 | Seed Round | $1.2M | ▮ | ▮ |
| May 2018 | Early Stage VC | $11.9M | ▮ | ▮ |
Membership and data by Private Market View
Vergent Bioscience valuation
Vergent Bioscience was valued at $75 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Vergent Bioscience raised?
Vergent Bioscience has raised $56.4 million across 5 recorded rounds since 2018. The largest was a $3.8 million seed round in Feb 2025; the most recent was an $18.7 million early-stage round in Oct 2025.
Vergent Bioscience has filed 7 Form Ds with the SEC since 2018, most recently in Feb 2025 ($3.8 million sold to 5 investors).
How Vergent Bioscience's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vergent Bioscience, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Vergent Bioscience
- What is Vergent Bioscience worth?
- Vergent Bioscience is valued at $75.0M as of Oct 2026. Valued at $75.0M at its later-stage round, Oct 2025. Nothing has traded since.
- How much has Vergent Bioscience raised?
- Vergent Bioscience has raised $56.4M in total funding across 5 recorded rounds.
- When did Vergent Bioscience last raise?
- Vergent Bioscience last raised in Oct 2025 (Early Stage VC), raising $18.7M.